RGS9–2 Negatively Modulates l-3,4-Dihydroxyphenylalanine-Induced Dyskinesia in Experimental Parkinson's Disease

Chronic l-dopa treatment of Parkinson's disease (PD) often leads to debilitating involuntary movements, termed l-dopa-induced dyskinesia (LID), mediated by dopamine (DA) receptors. RGS9–2 is a GTPase accelerating protein that inhibits DA D2 receptor-activated G proteins. Herein, we assess the f...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Neurosci
Huvudupphovsmän: Gold, Stephen J., Hoang, Chau V., Potts, Bryan W., Porras, Gregory, Pioli, Elsa, Kim, Ki Woo, Nadjar, Agnes, Qin, Chuan, LaHoste, Gerald J., Li, Qin, Bioulac, Bernard H., Waugh, Jeffrey L., Gurevich, Eugenia, Neve, Rachael L., Bezard, Erwan
Materialtyp: Artigo
Språk:Inglês
Publicerad: Society for Neuroscience 2007
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6673430/
https://ncbi.nlm.nih.gov/pubmed/18160641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.4223-07.2007
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk